RecruitingNot ApplicableNCT06643663

Role of GTR on Healing Outcome & Quality of Life in Combined Endo Perio Lesions With Communication

"Role of Guided Tissue Regeneration on Healing Outcome & Quality of Life in Combined Endo Perio Lesions With Communication: A Randomized Controlled Trial"


Sponsor

Postgraduate Institute of Dental Sciences Rohtak

Enrollment

30 participants

Start Date

May 23, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The recovery of periapical defects linked to periodontal communication frequently yields less satisfactory results. Numerous studies and case reports have highlighted the notable success achieved through the application of guided tissue regeneration techniques. More recently, autologous platelet concentrate plug \& placental membrane have emerged as a treatment option for addressing such lesions. Nevertheless, there has been no study using PRF-Medium with ACM membrane on the healing of aforesaid lesion \& quality of life assessment.


Eligibility

Min Age: 16 Years

Inclusion Criteria6

  • Patients of age 16yrs and above.
  • Patients with apico-marginal defects and deep pocket upto apex of tooth.
  • Failed primary root canal treatment.
  • Presence of interproximal bone loss.
  • Negative response to vitality test.
  • ASA-1 or ASA- 2 according to the classification of the American Society of Anesthesiologists)

Exclusion Criteria6

  • Presence of vertical root fracture
  • Presence of root perforations
  • ASA-3 or ASA-4 according to the classification of the American Society of Anesthesiologists)
  • Presence of root resorption
  • Combined endodontic-periodontic lesions.
  • Pregnancy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEndodontic Micro-Surgery

Surgery performed using ACM membrane and PRF plug in test group \& without membrane \& PRF in control group.


Locations(1)

Pgids Rohtak

Haryāna, India

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06643663


Related Trials